Clinical Trial

Investigating a Personalized Approach to Anti-Platelet Therapy

Name: Investigating a Personalized Approach to Anti-Platelet Therapy — clinical trial record (NCT07602257)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RAPID PREVENT

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

RAPID PREVENT aims to identify if a personalized (targeted) anti-platelet strategy will reduce bleeding events when compared to the current standard anti-platelet therapy.

Trial Details

NCT Number	NCT07602257
Lead Sponsor	Ottawa Heart Institute Research Corporation
Conditions	High Risk Bleeding
Enrollment	1,760 participants
Start Date	2026-06-01
Primary Completion	2029-12-28 (estimated)
Study Completion	2029-12-28 (estimated)
Updated on ClinicalTrials.gov	2026-05-22